166 related articles for article (PubMed ID: 36873167)
1. Iron-based and BRD
Geng L; Lu T; Jing H; Zhou Y; Liang X; Li J; Li N
Acta Pharm Sin B; 2023 Feb; 13(2):863-878. PubMed ID: 36873167
[TBL] [Abstract][Full Text] [Related]
2. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
3. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells.
Sui S; Zhang J; Xu S; Wang Q; Wang P; Pang D
Cell Death Dis; 2019 Apr; 10(5):331. PubMed ID: 30988278
[TBL] [Abstract][Full Text] [Related]
4. Multivalent Polypeptide and Tannic Acid Cooperatively Iron-Coordinated Nanohybrids for Synergistic Cancer Photothermal Ferroptosis Therapy.
He M; Du C; Xia J; Zhang ZG; Dong CM
Biomacromolecules; 2022 Jun; 23(6):2655-2666. PubMed ID: 35583462
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
[TBL] [Abstract][Full Text] [Related]
6. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
7. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
[TBL] [Abstract][Full Text] [Related]
8. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
[TBL] [Abstract][Full Text] [Related]
9. Iron-Based Nanovehicle Delivering Fin56 for Hyperthermia-Boosted Ferroptosis Therapy Against Osteosarcoma.
Zhang Y; Song Q; Zhang Y; Xiao J; Deng X; Xing X; Hu H; Zhang Y
Int J Nanomedicine; 2024; 19():91-107. PubMed ID: 38192634
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation and ferroptosis: The role of GSH and GPx4.
Ursini F; Maiorino M
Free Radic Biol Med; 2020 May; 152():175-185. PubMed ID: 32165281
[TBL] [Abstract][Full Text] [Related]
11. An active-passive strategy for enhanced synergistic photothermal-ferroptosis therapy in the NIR-I/II biowindows.
Wu F; Chen H; Liu R; Suo Y; Li Q; Zhang Y; Liu H; Cheng Z; Chang Y
Biomater Sci; 2022 Feb; 10(4):1104-1112. PubMed ID: 35044388
[TBL] [Abstract][Full Text] [Related]
12. MXene Quantum Dot/Zeolitic Imidazolate Framework Nanocarriers for Dual Stimulus Triggered Tumor Chemo-Phototherapy.
Feng X; Li M; Wang J; Zou X; Wang H; Wang D; Zhou H; Yang L; Gao W; Liang C
Materials (Basel); 2022 Jun; 15(13):. PubMed ID: 35806667
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
[TBL] [Abstract][Full Text] [Related]
14. FeP-Based Nanotheranostic Platform for Enhanced Phototherapy/Ferroptosis/Chemodynamic Therapy.
An N; Tang S; Wang Y; Luan J; Shi Y; Gao M; Guo C
Small; 2024 Mar; ():e2309940. PubMed ID: 38534030
[TBL] [Abstract][Full Text] [Related]
15. NIR Light-Activated and RGD-Conjugated Ultrasmall Fe/PPy Nanopolymers for Enhanced Tumor Photothermal Ferrotherapy and MR Imaging.
Zhang X; Wang T; Zhou Z; Zhao T; Shen Y; Fang W
Chemistry; 2023 Nov; 29(66):e202302125. PubMed ID: 37673787
[TBL] [Abstract][Full Text] [Related]
16. Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy.
Yu H; Yan J; Li Z; Song T; Ning F; Tan J; Sun Y
J Mater Chem B; 2023 Jan; 11(2):415-429. PubMed ID: 36512437
[TBL] [Abstract][Full Text] [Related]
17. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
18. NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury.
Feng Z; Qin Y; Huo F; Jian Z; Li X; Geng J; Li Y; Wu J
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166287. PubMed ID: 34626772
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
Zhu L; Meng D; Wang X; Chen X
ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
